期刊文献+

益气化瘀平肝滋肾方对高血压早期肾损害患者CysC、β2-MG、MAlb及肾动脉血流动力学的影响观察 被引量:3

Effects of Yiqi Huayu Pinggan Zishen Recipe on CysC,β-mg,mAlb and Renal Artery Hemodynamics inHypertension Patients with Early Renal Damage
下载PDF
导出
摘要 目的:观察益气化瘀平肝滋肾方对高血压早期肾损害患者胱抑素C(CysC)、微量白蛋白(mAlb)、β2微球蛋白(β2-MG)及肾动脉血流动力学的影响。方法:115例高血压早期肾损害患者随机分为观察组(58例)和对照组(57例)。对照组给予常规西医治疗,观察组在对照组基础上加用益气化瘀平肝滋肾方治疗。连续治疗3个疗程后,比较两组治疗效果和药品不良反应发生情况,以及治疗前后中医证候积分、血压[收缩压(SBP)、舒张压(DBP]、肾损害指标(血清CysC、尿mAlb、β2-MG)、肾动脉血流动力学[舒张末期流速(EDV)、收缩期峰值流速(PSV)、肾动脉阻力指数(RI)]等指标变化。结果:观察组总有效率明显高于对照组(91.38%vs.73.68%,P<0.05)。治疗后,两组患者的中医证候积分,SBP、DBP,血清CysC、尿β2-MG、MAlb水平,肾动脉EDV、PSV、RI等各项指标均较治疗前显著改善(P<0.05);且观察组上述指标均明显优于对照组(P<0.01)。两组药品不良反应发生率差异无统计学意义(P>0.05)。结论:在常规西医治疗基础上益气化瘀平肝滋肾方治疗高血压早期肾损害,疗效确切,能有效减轻症状,改善血压、肾功能,调节肾动脉血流动力学,安全可靠。 Objective:To explore the effects of Yiqi Huayu Pinggan Zishen recipe on cystatin C(CysC),microalbumin(mAlb),β2 microglobulin(β2-MG)and renal artery hemodynamics in hypertensionpatients with early renal damage.Methods:A total of 115 hypertensionpatients with early renal impairment were treated in our hospital from August 2017 to December 2018 as the research objects,and according to the random number table method,they were divided into observation group(58 cases)and control group(57 cases).The control group was treated with the conventional western medicine,and the observation group was treated with Yiqi Huayu Pinggan Zishen recipe based on the control group.The therapeutic effects,TCM syndrome scores,blood pressure[systolic blood pressure(SBP),diastolic blood pressure(DBP)],renal damage indicators(serum CysC,urine mAlb,β2-MG),renal arterial hemodynamics[end-diastolic velocity(EDV),peak systolic velocity(PSV),renal artery resistance index(RI)]and adverse events were compared between the two groups.Results:The total effective rate in the observation group was higher than that in the control group(91.38%vs.73.68%,P<0.05).The scores of TCM syndromes,levels of SBP and DBP,and serum levels of CysC,urineβ2-MG and MAlb in the observation group were lower than those in the control group after 3 courses of treatment,the renal artery EDV and PSV in the observation group were higher than those in the control group,and the RI was lower than that in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion:On the basis of conventional western medicine treatment,Yiqi Huayu Pinggan Zishen recipe is the first treatment method for early renal damage in hypertension with definite efficacy,which can effectively reduce symptoms,improve blood pressure and renal function,and regulate renal artery hemodynamics with promising safety and reliability.
作者 裴朝华 王鹏 方芳 曹岩 Pei Chaohua;Wang Peng;Fang Fang;Cao Yan(Division II,Depaitment of Nephrology,Tangshan Hospital of Traditional Chinese Medicine,Hebei Tangshan 063000,China;Division I,Departmentof Cardiology,Tangshan Hospital of Traditional Chinese Medicine,Hebei Tangshan 063000,China)
出处 《中国药师》 CAS 2020年第11期2184-2187,共4页 China Pharmacist
基金 河北省中医药管理局科研计划项目(编号:2018314)。
关键词 益气化瘀平肝滋肾方 高血压早期肾损害 血压 肾动脉血流动力学 胱抑素C 尿微量白蛋 β2微球蛋白 Yiqi Huayu Pinggan Zishen recipe Early renal damage in hypertension Blood pressure Renal artery hemodynamics Cystatin C Urine microalbumin β2 Microglobulin
  • 相关文献

参考文献13

二级参考文献149

  • 1王东,蒋湘莲,聂亚雄.高血压大鼠模型的研究进展[J].中国动脉硬化杂志,2006,14(3):271-273. 被引量:32
  • 2于江月,李树青.黄芪对自发性高血压大鼠早期肾组织NO和NOS的影响[J].心脏杂志,2007,19(4):406-408. 被引量:20
  • 3中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,390:579-616. 被引量:93
  • 4中国高血压防治指南修订委员会.2011年高血压诊治指南.中华心血管杂志,2011,9:579-616. 被引量:2
  • 5白国军.蒙药党参-18味治疗银屑病临床体会[J].中国民族医药杂志,2007,13(8):25-25. 被引量:4
  • 6Vasan RS, Larson MG, Leip EP, et al. Assessment of fre- quency of progression tohypertension in nonhypertensivepartic ipants in the Framingham Heart Study: acohort study[J]. Lancet, 2001, 358(9294) : 1682-1686. 被引量:1
  • 7Lewington S, Clarke R, Qizilbash N, et al. Age-specific rele- vance of usual blood pressure to vascularmortality: a meta-a- nalysis of individual data for one million adultsin 61 prospective studies[J]. Lancet, 2002, 360(9349): 1903-1913. 被引量:1
  • 8Chobanian AV, Bakris GL, Black HR, et al. Seventh Report () the Joint National Committee Oil Prevention, Detection, E- valuation, and Treatment of High Blood Pressure: the JNC 7 report [J]. Hypertension, 2003, 42(6): 1206-1252. 被引量:1
  • 9Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart dis- ease and stroke risk factors in persons with prehypertension in the United States, 1999-2000[J]. Arch Intern Med, 2004, 164(19): 2l. 被引量:1
  • 10Kim BJ, Lee HJ, Sung KC, et al. Comparision of microalbu- minuria in 2 blood pressure categories of prehypertensivesub jeets[J]. Circ J, 2007, 7t (8): 1283-1287. 被引量:1

共引文献231

同被引文献39

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部